Cesca Therapeutics I (KOOL) 4.10 $KOOL Cesca

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cesca Therapeutics I (KOOL) 4.10 $KOOL

Cesca Therapeutics Announces Conversion of $12.5 Million in Senior Secured Debt to Equity
GlobeNewswire - Wed Aug 24, 8:00PM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has converted a senior secured three year convertible debenture of $12.5 million of principal and $8.25 million of interest to 6,102,941 shares of its common stock. The conversion was effected in accordance with the previously announced purchase agreement entered into between Cesca Therapeutics and Boyalife USA, dated February 2, 2016. It releases Cesca from all security interest and liens previously placed against the Company's assets and eliminates Boyalife's entitlement to certain participation rights in, or consent rights over, potential future equity and debt financings.
KOOL: 4.10 (-0.07)

Cesca Therapeutics Announces Pricing of $2.5 Million Registered Direct Offering
GlobeNewswire - Thu Aug 04, 8:08AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it has entered into definitive subscription agreements with institutional investors to purchase 600,000 shares of common stock at a purchase price per share of $4.10 for gross proceeds of approximately $2.5 million in a registered direct offering. No warrants were issued to investors in the offering. The closing of the transaction is expected to occur on August 9, 2016, subject to the satisfaction of customary closing conditions.
KOOL: 4.10 (-0.07)

Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study
GlobeNewswire - Wed Aug 03, 5:00AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced 40-month follow-up results for a number of patients that participated in the Company's earlier feasibility study using Cesca's proprietary SurgWerks(TM) system for the treatment of late stage, "no option" critical limb ischemia (CLI).
KOOL: 4.10 (-0.07)

Cesca Therapeutics Announces Publication of Results on Use of Its Technology for Treatment of Non-Union Fracture
GlobeNewswire - Tue Aug 02, 5:01AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that data for its proprietary technology was published in the Herald Scholarly Open Access (HSOA) Journal of Stem Cells Research, Development and Therapy, which is available online at http://ow.ly/ZFzM300Yt1m.
KOOL: 4.10 (-0.07)

Cesca Therapeutics Provides Update on FDA Review of Investigational Device Exemption Supplement for SurgWerks(TM) CLI Pivotal Trial
GlobeNewswire - Mon Aug 01, 5:00AM CDT
FDA Approves Commencement of Phase III Pivotal Trial as Amended
KOOL: 4.10 (-0.07)

Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors
GlobeNewswire - Mon Jun 20, 5:05AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Mark Bagnall has been appointed to the Company's Board of Directors, effective July 1, 2016.
KOOL: 4.10 (-0.07)

Cesca Therapeutics to Exhibit at 14th International Cord Blood Symposium
GlobeNewswire - Wed Jun 08, 5:05AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be exhibiting at the 14 International Cord Blood Symposium (ICBS), being held June 9-11 at the Hyatt Regency Hotel in San Francisco, California. As a leader in concentrating and cryopreserving stem cells from cord blood, Cesca is proud to sponsor the event.
KOOL: 4.10 (-0.07)

Cesca Therapeutics to Present at the LD Micro Invitational Conference
GlobeNewswire - Mon Jun 06, 5:05AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Michael Bruch, the Company's Chief Financial Officer and Dalip Sethi, Ph.D., Clinical Research Director, will discuss recent corporate developments and initiatives at the LD Micro Invitational, being held June 7 - 9, 2016 at the Luxe Sunset Hotel in Los Angeles.
KOOL: 4.10 (-0.07)

Cesca Therapeutics Submits Investigational Device Exemption Supplement for SurgWerks(TM) CLI Pivotal Trial
GlobeNewswire - Wed Jun 01, 10:15AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has submitted an Investigational Device Exemption (IDE) Supplement to the U.S. Food and Drug Administration (FDA) for its previously approved pivotal trial for the treatment of patients with critical limb ischemia (CLI), using the Company's SurgWerks system. The Company expects the FDA to submit its response to the IDE supplement within 30 days of submission.
KOOL: 4.10 (-0.07)

Cesca Therapeutics to Exhibit at the 2016 International Society for Cellular Therapy Annual Meeting
GlobeNewswire - Tue May 24, 5:00AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be exhibiting at the 2016 International Society for Cellular Therapy (ISCT) Annual Meeting in Booth B06 on May 25-28, 2016 at the Suntec Convention and Exhibition Center in Suntec City, Singapore.
KOOL: 4.10 (-0.07)

Cesca Therapeutics to Review Recent Corporate Milestones at the Marcum MicroCap Conference
GlobeNewswire - Fri May 20, 5:00AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company's management team including, Mr. Robin Stracey, Chief Executive Officer, Mr. Michael Bruch, Chief Financial Officer and Dalip Sethi, Ph.D., Clinical Research Director, will discuss recent corporate developments and initiatives at the Marcum MicroCap Conference, which is being held June 1 - 2, 2016 at the Grand Hyatt Hotel in New York City.
KOOL: 4.10 (-0.07)

4 Stocks to Watch on Thursday May 19
ACCESSWIRE - Thu May 19, 1:02PM CDT
CORAL GABLES, FL / ACCESSWIRE / May 19, 2016 / TechStockInsider.com issues the following report: Today is an historic day in the market. It marks the anniversary of The Dow Jones Industrial Average having a record close of 18,312.39. But despite this very positive high in market history, investors have been hit with a rocky trading session on Thursday morning. This has left many, searching for stocks that have found an uptrend and we have been able to identify four stocks that investors are buying up on May 19.
KOOL: 4.10 (-0.07), PRGN: 0.73 (-0.03), GLBS: 0.65 (+0.01)

Cesca Therapeutics Announces Publication of a Case Report on Use of Its Technology for Treatment of Acute Myocardial Infarction
GlobeNewswire - Thu May 19, 5:00AM CDT
Data highlights promising results obtained from the AMIRST pilot study.
KOOL: 4.10 (-0.07)

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update
GlobeNewswire - Thu May 12, 3:37PM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today reported financial results for the third quarter of fiscal 2016 and provided an update to investors that included the status of clinical initiatives, with a particular emphasis on the Company's critical limb ischemia (CLI) program. The Company expects to submit an Investigational Device Exemption (IDE) supplement to the FDA at the end of the month detailing a range of changes to the pivotal CLI trial design and amendments to its CLI study protocol. The supplement will touch on, among other things, study end-points, the statistical analysis plan, the required patient enrollment totals for both the treatment arm and the control arm, patient inclusion/exclusion criteria and protocol changes designed to enhance patient enrollment.
KOOL: 4.10 (-0.07)

Cesca Reports Data From Six CLI Compassionate Use Patients Treated With SurgWerks(TM) Procedures at Fortis Escorts Heart Institute in New Delhi
GlobeNewswire - Wed May 11, 5:00AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced the results of six late-stage critical limb ischemia (CLI) patients treated with its SurgWerks(TM)-CLI system on a compassionate use basis. In a six-month follow-up of the patients, they reported favorable outcomes in lifestyle and pain reduction. The procedures were conducted by Dr. Suhail Bukhari of the Fortis Escorts Heart Institute and Research Center in New Delhi, India.
KOOL: 4.10 (-0.07)

Cesca Therapeutics to Report Third Quarter Fiscal 2016 Results on May 12, 2016
GlobeNewswire - Mon May 09, 5:00PM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report financial results for the fiscal third quarter ended March 31, 2016 and provide a status update to investors on Thursday, May 12, 2016.
KOOL: 4.10 (-0.07)

Cesca Therapeutics To Present A Poster At The 2016 Annual Meeting Of The European Society For Blood And Bone Marrow Transplantation
GlobeNewswire - Thu Mar 31, 5:05AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will present a poster titled "Volume Reduction and RBC Depletion of Apheresis Products for Transplant" at the 42 Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT) to be held in Valencia, Spain on April 3 - 6, 2016.
KOOL: 4.10 (-0.07)

Cesca Therapeutics' Indian Subsidiary Expands Cord Blood Banking Services To Additional Hospitals In The Fortis Healthcare Network
GlobeNewswire - Wed Mar 30, 5:05AM CDT
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that its wholly-owned subsidiary in India, TotipotentRX, has expanded its private cord blood banking services into several hospitals within the Fortis Healthcare network in South and West India.
KOOL: 4.10 (-0.07)

Texas Stem Cell Enters Into an Agreement With Cesca Therapeutics for Use of AutoXpress(R) Technology for Cord Blood Processing
GlobeNewswire - Tue Feb 09, 5:00AM CST
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Texas Stem Cell has committed to utilizing Cesca's AutoXpress(R) AXP technology for its cord blood banking business. The AXP platform includes a 'smart' processing device and sterile disposable that automatically concentrates the stem cells from a cord blood unit in less than one hour and delivers them directly into Cesca's patented sample bag which is optimized for cryopreservation and storage. Cesca's AXP technology is widely used in cord blood banks around the world and has been referenced in dozens of clinical publications. Recently, clinical focus on cord blood has expanded due to the emergence of protocols enabling the expansion of cord blood cells in vitro, for subsequent therapeutic use in treatments for many forms of blood cancers including leukemia and lymphomas.
KOOL: 4.10 (-0.07)

Cell Therapy Industry: The Roads to Commercial Success
ACCESSWIRE - Wed Feb 03, 8:15AM CST
REDONDO BEACH, CA / ACCESSWIRE / February 3, 2016 / A recent panel discussion at the Alliance for Regenerative Medicine State of the Industry Briefing (associated with Biotech Showcase 2016 in San Francisco) raised the issue of bio-manufacturing scale up for cell therapies as a great need for continued development (see webcast here: http://alliancerm.org/event/regenerative-medi...-briefing). Among representatives of large pharmaceutical companies, or biotech companies partnered for development with large pharmaceutical companies, there was a general consensus that scaling up manufacturing for production of cell therapeutics was still a work in progress, and after nearly a decade of investment, more expertise and new technologies were required prior to commercialization.
KOOL: 4.10 (-0.07), MESO: 4.96 (unch), PFE: 34.77 (+0.09), CLLS: 26.40 (unch), NVS: 79.38 (+1.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 61

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 55

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 90

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading

Top 5 Most Recently Viewed Articles

GoldHaven Resources Expands Exploration Amid Robust Gold Prices

Updated Category News Views 299

Gold's Resilience Fuels Growth Initiatives Gold prices have steadily stabilized above $4,200 per ounce, prompting renewed interest among investors seeking safe-haven assets. This robust price environment encourages extensive drilling programs aimed at expanding resource bases. GoldHaven Resources Corp. (CSE: GOH) is at the forefront of this momentum, actively advancing...

Continue Reading
HSBC Highlights Reliance Industries' Growth Potential and Strategy

Updated Category News Views 287

HSBC Upgrades Reliance Industries Stock Target Recently, HSBC raised its price target for Reliance Industries (RIL:IN) from INR 2,780.00 to INR 3,010.00 while maintaining a Hold rating. This revision reflects a promising outlook on the company's comprehensive business structure and financial standing. Core Sectors Driving Performance HSBC's analysts highlighted Reliance's...

Continue Reading
Vallourec's Strategic Move: Partial Redemption of Notes

Updated Category News Views 142

Vallourec's Strategic Financial Maneuver Vallourec, an industry leader in premium tubular solutions, has made a significant announcement regarding its senior notes due 2032. This decision is part of its ongoing strategy to enhance its financial stability and market position. Details of the Partial Redemption The company plans to redeem $82 million of its senior notes,...

Continue Reading
Health Assurance Foundation Teams Up to Enhance Healthcare Access

Updated Category News Views 80

The Health Assurance Foundation officially launched as a nonprofit back in 2024, focusing on strengthening the healthcare system by investing in local communities. Its mission? Making healthcare more equitable and accessible for everyone. Sounds good on paper, right? But when you peel back the layers, things get murky. Community Health Worker Initiative: Is It Enough? The...

Continue Reading
Market Pay Unveils Seamless POS Solution for Merchants Across Europe

Updated Category News Views 208

Market Pay Launches a Game-Changing Payment Solution The French fintech company Market Pay, a prominent player in the European payment processing field, is excited to unveil its new point-of-sale software payment solution. This innovative app integrates both terminal and smartphone payment options into a single, user-friendly platform. This development not only simplifies...

Continue Reading